
CAS: 1187990-87-9

N-[Bis(4-methoxyphenyl)methyl]-1,6-dihydro-6-oxo-2-(3-pyridazinyl)-5-pyrimidinecarboxamide
CAS:1187990-87-9
Formula:
C24H21N5O4
Purity:
97%
Color and Shape:
Solid
Molecular weight:
443.4546
Ref: IN-DA0096T2
5mg | 51.00 € | ||
10mg | 68.00 € |
Estimated delivery in United States, on Tuesday 12 Aug 2025

Ref: 54-BUP13184
5mg | 65.00 € | ||
10mg | 104.00 € | ||
25mg | 211.00 € | ||
50mg | 343.00 € | ||
100mg | 550.00 € | ||
500mg | 1,010.00 € |
Estimated delivery in United States, on Wednesday 13 Aug 2025

N-[Bis(4-Methoxyphenyl)Methyl]-4-Hydroxy-2-Pyridazin-3-ylpyrimidine-5-Carboxamide
CAS:1187990-87-9
Purity:
97%
Molecular weight:
443.45g/mol
Ref: 54-OR1026003
1g | 670.00 € | ||
5g | 2,911.00 € | ||
100mg | 125.00 € | ||
250mg | 201.00 € |
Estimated delivery in United States, on Wednesday 13 Aug 2025

MK-8617
CAS:1187990-87-9
MK-8617 is an orally available HIF PHD1 3 pan-inhibitor, inhibiting PHD1/2/3 (IC50: 1.0/1.0/14 nM).
Formula:
C24H21N5O4
Purity:
100% - 99.38%
Color and Shape:
Solid
Molecular weight:
443.45
Ref: TM-T4106
5mg | 48.00 € | ||
10mg | 74.00 € | ||
25mg | 145.00 € | ||
50mg | 235.00 € | ||
100mg | 393.00 € | ||
200mg | 560.00 € |
Estimated delivery in United States, on Tuesday 19 Aug 2025

N-[bis(4-methoxyphenyl)methyl]-6-oxo-2-(pyridazin-3-yl)-1,6-dihydropyrimidine-5-carboxamide
CAS:1187990-87-9
Purity:
95%
Molecular weight:
443.4630126953125
Ref: 10-F811127
5mg | To inquire | ||
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Friday 22 Aug 2025

MK 8617
CAS:1187990-87-9
Hypoxia inducible prolyl hydroxylase 1-3 (HIF PHD 1-3) inhibitor
Formula:
C24H21N5O4
Purity:
Min. 95%
Molecular weight:
443.45 g/mol
Ref: 3D-BM170837
10mg | 305.00 € | ||
50mg | 650.00 € |
Estimated delivery in United States, on Tuesday 23 Sep 2025